Search Results - "Pai, H.H"

Long-Term Prostate-Specific Antigen Stability and Predictive Factors of Failure After Permanent Seed Prostate Brachytherapy by Tetreault, A, Crook, J.M, Hamm, J, Pickles, T, Keyes, M, McKenzie, M, Pai, H.H, Bachand, F, Morris, W.J

Get full text

Low-Dose-Rate Prostate Brachytherapy Is Superior to Dose-Escalated EBRT for Unfavorable Risk Prostate Cancer: The Results of the ASCENDE-RT Randomized Control Trial by Rodda, S.L, Tyldesley, S, Keyes, M, McKenzie, M, Pai, H.H, Duncan, G, Hamm, J, Morris, W.J

Get full text

PO-46: CTLA-4 Blockade with Androgen Deprivation and Radiotherapy for the Treatment of Prostate Cancer by Blood, P.A, Johnson, L.D.S, Beckham, W.A, Russell, G, Pai, H.H, Lim, J.T, Richier, L.R, Nelson, B.H, Vlachaki, M.T, Lum, J.J

Get full text

Health problems among international travellers: From a subtropical region to tropical and non-tropical regions by Pai, H.H, Wang, W.T, Lai, J.L

“…International travel may be associated with the risk of a wide range of infectious diseases. This study was designed to obtain information on the health…”
Get full text

Evaluating Toxicity and Interaction Outcomes of Systemic Therapy and Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Secondary Analysis of the Phase II SABR-5 Trial by Kooyman, A., Chang, J.S., Liu, M., Jiang, W., Bergman, A., Schellenberg, D., Mou, B., Alexander, A.S., Carolan, H., Hsu, F., Atrchian, S., Chan, E.K., Berrang, T., Chng, N., Matthews, Q., Pai, H.H., Valev, B., Tyldesley, S., Olson, R.A., Baker, S.

“…While SABR is known for its overall low toxicity and safety, there remains a research gap regarding its combined use with specific systemic therapies. This…”
Get full text

An Updated Analysis of Survival Endpoints for ASCENDE-RT, a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer by Oh, J., Tyldesley, S., Pai, H.H., McKenzie, M.R., Halperin, R.M., Duncan, G.G., Morton, G., Keyes, M., Hamm, J., Morris, W.J.

Get full text

Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR): Overall Survival Results of the SABR-5 Trial by Jiang, W.N., Baker, S., Liu, M., Bergman, A., Schellenberg, D., Mou, B., Alexander, A.S., Carolan, H., Atrchian, S., Chan, E.K., Mohamed, I.G., Berrang, T., Bang, A., Chng, N., Matthews, Q., Pai, H.H., Lefresne, S., Tyldesley, S., Olson, R.A.

Get full text

Stereotactic Ablative Radiotherapy for Oligo-Progressive Cancers: Results of the Randomized Phase II STOP Trial by Schellenberg, D., Gabos, Z., Duimering, A., Debenham, B.J., Fairchild, A., Huang, F., Rowe, L., Severin, D.M., Giuliani, M., Bezjak, A., Lok, B.H., Raman, S., Chung, P., Zhao, Y., Ho, C., Lock, M.I., Louie, A., Lefresne, S., Carolan, H., Liu, M.C., Yau, V., Ye, A.Y., Olson, R.A., Mou, B., Mohamed, I.G., Petrik, D.W., Dosani, M., Pai, H.H., Valev, B., Gaede, S., Warner, A., Palma, D.A.

“…In the metastatic setting, there is uncertain benefit to localized eradication of one or more lesions that are progressing despite systemic therapy. This…”
Get full text

Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR) for up to 5 Oligometastases: Preliminary Results of the SABR-5 Trial by Olson, R.A., Jiang, W., Liu, M.C., Bergman, A., Schellenberg, D., Mou, B., Alexander, A.S., Carolan, H., Hsu, F., Miller, S., Atrchian, S., Chan, E.K., Ho, C., Mohamed, I.G., Lin, A., Berrang, T., Bang, A., Chng, N., Matthews, Q., Huang, V., Mestrovic, T., Hyde, D., Lund, C.R., Pai, H.H., Valev, B., Lefresne, S., Tyldesley, S..

“…After the publication of the landmark SABR-COMET trial, concerns were raised over toxicity of SABR for oligometastases. This population-based study was…”
Get full text

Meeting the health information needs of prostate cancer patients using personal health records by Pai, H H, Lau, F, Barnett, J, Jones, S

“…There is interest in the use of health information technology in the form of personal health record (phr) systems to support patient needs for health…”
Get full text

Isolation of non-tuberculous mycobacteria from hospital cockroaches ( Periplaneta americana) by Pai, H.H, Chen, W.C, Peng, C.F

“…This study attempted to isolate mycobacteria from hospital and household cockroaches from 90 hospitals and 40 households in Kaohsiung City and Kaohsiung…”
Get full text